NSCLC STAGE II
Clinical trials for NSCLC STAGE II explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE II trials appear
Sign up with your email to follow new studies for NSCLC STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for shrinking lung tumors before surgery
Disease control Recruiting nowThis study is for people with stage II or III non-small cell lung cancer who are scheduled for surgery. It tests whether giving a combination of two immunotherapy drugs (sintilimab and IBI310) plus chemotherapy before surgery can shrink tumors more effectively. The goal is to see…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo aims to shield scarred lungs from radiation damage
Disease control Recruiting nowThis study tests whether adding BIO 300 to standard chest radiation can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease (lung scarring). About 25 adults will receive the combination and b…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Can tailored workouts help lung cancer patients? new study aims to find out
Symptom relief Recruiting nowThis study tests whether a personalized exercise program, delivered through telehealth, is practical for people with stage II or III lung cancer who are receiving treatments like chemotherapy or immunotherapy. Researchers will track how many patients join and stick with the progr…
Matched conditions: NSCLC STAGE II
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC